TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Lame Duck NCI Director: Cancer Centers Should Run Cancer Clinical Trials System June 25, 2010
TCL Archive First Test Of Cooperative Groups’ Willingness To Change Coming In New Colorectal Trials November 14, 1986
TCL Archive A Misdirected Email: CPRIT Official Speaks of “New Regime” As Institute Denies Deepening Crisis October 19, 2012
TCL Archive SWOG Study To Test Predictive Value Of Circulating Tumor Cells In Breast Cancer October 27, 2006
